The Association of Clinicopathological Features with Metastatic Status in Infiltrative Urothelial Carcinoma of Bladder

  • Siska Dwiyantie Wahyuni Departement of Anatomical Pathology, Padjadajaran University, Hasan Sadikin Hospital
  • Sri Suryanti Anatomical Pathology Department Faculty of Medicine University of Padjadjaran/Hasan Sadikin Hospital Bandung, Indonesia
  • Hasrayati Agustina Anatomical Pathology Department Faculty of Medicine University of Padjadjaran/Hasan Sadikin Hospital Bandung, Indonesia
  • Bethy Suryawathy Hernowo Anatomical Pathology Department Faculty of Medicine University of Padjadjaran/Hasan Sadikin Hospital Bandung, Indonesia

Abstract

Background: Infiltrative urothelial carcinoma of bladder is an aggressive variant of bladder carcinoma. Most of the patients in their first encounter with doctors are diagnosed with advanced stages and many has metastasized. Metastasis is a process of malignant tumor cells migrating from its primary tumor location to other organs or sites inside the body via blood circulation or lymphatic system. Metastasis process is responsible for 90% cancer deaths compared to the primary tumor itself, infiltrative urothelial carcinoma of bladder. To reduce mortality, knowledge of the clinicopathological characteristics associated with metastasis is needed.


Method: Research material used was clinical data and paraffin block from patients with metastatic and non-metastatic infiltrative urothelial carcinoma of bladder. Clinical data taken from Central Medical Record Installation and Urology Medical Record Installation Padjadjaran University/ Dr. Hasan Sadikin Hospital Bandung, Indonesia. Paraffin blocks were obtained from operations at Hasan Sadikin Hospital Bandung, Indonesia.Total data sample obtained were 40 samples, 20 samples are metastatic and another 20 are non-metastatic samples. Clinicopathological parameters included in the analysis were age, sex and pathalogical T stage.


Result: Pathalogical T stage have associations with metastatic status with significant result with p value=0.035 (p<0.005).


Conclusion: Pathalogical T stage was associated with the metastatic status of Infiltrative urothelial carcinoma of bladder and may play important roles during the metastatic process. Thus, it can be used as a predictor factor for the infiltrative urothelial carcinoma of bladder.


Keywords: infiltrative urothelial carcinoma of bladder, metastastic, pathalogical T stage

Keywords: infiltrative urothelial carcinoma of bladder, metastastic, pathalogical T stage

Downloads

Download data is not yet available.

Author Biographies

Siska Dwiyantie Wahyuni, Departement of Anatomical Pathology, Padjadajaran University, Hasan Sadikin Hospital

Anatomical Pathology Department Faculty of Medicine University of Padjadjaran/Hasan Sadikin Hospital Bandung, Indonesia

Sri Suryanti, Anatomical Pathology Department Faculty of Medicine University of Padjadjaran/Hasan Sadikin Hospital Bandung, Indonesia

Anatomical Pathology Department Faculty of Medicine University of Padjadjaran/Hasan Sadikin Hospital Bandung, Indonesia

Hasrayati Agustina, Anatomical Pathology Department Faculty of Medicine University of Padjadjaran/Hasan Sadikin Hospital Bandung, Indonesia

Anatomical Pathology Department Faculty of Medicine University of Padjadjaran/Hasan Sadikin Hospital Bandung, Indonesia

Bethy Suryawathy Hernowo, Anatomical Pathology Department Faculty of Medicine University of Padjadjaran/Hasan Sadikin Hospital Bandung, Indonesia

Anatomical Pathology Department Faculty of Medicine University of Padjadjaran/Hasan Sadikin Hospital Bandung, Indonesia

References

1. Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of Bladder Cancer. Medical sciences (Basel, Switzerland). 2020 Mar 13; 8(1).
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018 Nov; 68(6):394-424.
3. Fred T. Bosman MP ESJM, Sunil R.Lakhani MF, Hiroko Ohgaki. P.Tumours of the urinary tract. In: Holger Moch PAH, Thomas M.U I bright, Victor E.Reuter (Eds), editor. WHO Classification of Tumours of the Urinary System and Male Genital Organs.4 ed.Lyon, France: International Agency for Research on Cancer (IARC) Press: International Agency for Research on Cancer (IARC) Press; 2016.hlm.77-106. 2016; 77-106.
4. Cheng L, Lopez-Beltran A, Bostwick DG. Bladder Pathology: John Wiley & Sons; 2012.
5. Miyazaki J, Nishiyama H. Epidemiology of urothelial carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2017 Oct; 24(10):730-4.
6. Arvelo F, Sojo F, Cotte C. Tumour progression and metastasis. Ecancermedicalscience. 2016; 10:617.
7. Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduction and Targeted Therapy. 2020 2020/03/12; 5(1):28.
8. Otsuka M, Taguchi S, Nakagawa T, Morikawa T, Maekawa S, Miyakawa J, et al. Clinical significance of random bladder biopsy in primary T1 bladder cancer. Mol Clin Oncol. 2018 2018/05/01; 8(5):665-70.
9. Amin MB, Epstein JI, Reuter VE. Biopsy interpretation of the bladder. Philadelphia, PA: Wolters Kluwer; 2017.
10. Matulay JT KA. Epidemiology and Etiology of Bladder Cancer. Uro Today. 2019.
11. Li Y, Chen M, Yuan J, Zhou X, He W, Zu X, et al. CXCR4 Expression in Bladder Transitional Cell Carcinoma and Its Relationship with Clinicopathological Features. Urologia Internationalis. 2014; 92(2):157-63.
12. Kim SH, Song MK, Joung JY, Chung J, Lee KH, Seo HK. Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma. Investigative and clinical urology. 2019 Nov; 60(6):432-42.
13. Reis ST, Leite KRM, Piovesan LF, Pontes-Junior J, Viana NI, Abe DK, et al. Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer. BMC Urology. 2012 2012/06/13; 12(1):18.
14. Retz MM, Sidhu SS, Blaveri E, Kerr SC, Dolganov GM, Lehmann J, et al. CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. 2004.
15. Li J, Guo BC, Sun LR, Wang JW, Fu XH, Zhang SZ, et al. TNM staging of colorectal cancer should be reconsidered by T stage weighting. World journal of gastroenterology. 2014 May 7; 20(17):5104-12.
16. Yousef EM, Tahir MR, St-Pierre Y, Gaboury LA. MMP-9 expression varies according to molecular subtypes of breast cancer. BMC cancer. 2014 Aug 23; 14:609.
Statistics
38 Views | 25 Downloads
How to Cite
1.
Wahyuni S, Suryanti S, Agustina H, Hernowo BS. The Association of Clinicopathological Features with Metastatic Status in Infiltrative Urothelial Carcinoma of Bladder. JDDT [Internet]. 18Dec.2020 [cited 21Jan.2021];10(6-s):99-02. Available from: http://jddtonline.info/index.php/jddt/article/view/4647